Phylloquinone and vitamin D status: Associations with incident chronic kidney disease in the framingham offspring cohort

American Journal of Nephrology

Volumn 36, Issue 1, 2012, Pages 68-77

  O'Seaghdha, Conall M ^a,b   Hwang, Shih Jen ^a   Holden, Rachel ^e   Booth, Sarah L ^d   Fox, Caroline S ^a,c  

^a FRAMINGHAM HEART STUDY   (United States)

^b Renal Division   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TUFTS UNIVERSITY   (United States)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Chronic kidney disease; Vitamin D; Vitamin K

Indexed keywords

ALBUMIN; CREATININE; PHYTOMENADIONE; VITAMIN D;

ADULT; ALBUMINURIA; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK ASSESSMENT; VASCULAR DISEASE; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

ADULT; AGED; ALBUMINURIA; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK; TREATMENT OUTCOME; VITAMIN D; VITAMIN K; VITAMIN K 1;

EID: 84862506176     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000339005     Document Type: Article

References (51)

1. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
2. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE: Coronary artery calci-fication in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004; 44: 1024-1030. (Pubitemid 39556482)
3. Hujairi NM, Afzali B, Goldsmith DJ: Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 2004; 43: 234-243. (Pubitemid 38146321)
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
5. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal dis-ease. Circulation 1999; 99: 2434-2439. (Pubitemid 29218240)
6. Garcia-Canton C, Bosch E, Ramirez A, Gon-zalez Y, Auyanet I, Guerra R, et al: Vascular calcification and 25-hydroxyvitamin D lev-els in non-dialysis patients with chronic kid-ney disease stages 4 and 5. Nephrol Dial Transplant 2011; 26: 2250-2256.
7. Hruska KA, Mathew S, Davies MR, Lund RJ: Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives. Kidney Int Suppl 2005; 99: 142-151.
8. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL: Vitamins K and D sta-tus in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 590-597.
9. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ: Vita-min K and the prevention of fractures: sys-tematic review and meta-analysis of ran-domized controlled trials. Arch Intern Med 2006; 166:1256-1261. (Pubitemid 43967576)
10. Wolff AE, Jones AN, Hansen KE: Vitamin D and musculoskeletal health. Nat Clin Pract Rheumatol 2008; 4: 580-588.
11. Shobeiri N, Adams MA, Holden RM: Vascu-lar calcification in animal models of CKD: a review. Am J Nephrol 2010; 31:471-481.
12. Krueger T, Westenfeld R, Ketteler M, Schur-gers LJ, Floege J: Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int 2009; 76: 18-22.
13. Zittermann A, Schleithoff SS, Koerfer R: Vi-tamin D and vascular calcification. Curr Opin Lipidol 2007; 18: 41-46.
14. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al: Dietary intake of menaquinone is as-sociated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-3105. (Pubitemid 39470091)
15. Young KA, Snell-Bergeon JK, Naik RG, Ho-kanson JE, Tarullo D, Gottlieb PA, et al: Vi-tamin D deficiency and coronary artery cal-cification in subjects with type 1 diabetes. Diabetes Care 2011; 34: 454-458.
16. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C: Regres-sion of warfarin-induced medial elastocalci-nosis by high intake of vitamin K in rats. Blood 2007; 109:2823-2831. (Pubitemid 46482077)
17. Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, et al: Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int 2010; 77: 1000-1009.
18. Zhang Y, Deb DK, Kong J, Ning G, Wang Y Li G, et al: Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 re-ceptor antagonist. Am J Physiol Renal Physi-ol 2009; 297:F791-F801.
19. De Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al: Selective vita-min D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010; 376: 1543-1551.
20. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families. The Framingham Offspring Study. Am J Epide-miol 1979; 110:281-290. (Pubitemid 10204328)
21. Davidson KW, Sadowski JA: Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatogra-phy using postcolumn chemical reduction and fluorimetric detection. Methods Enzy-mol 1997; 282:408-421. (Pubitemid 27412792)
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rog-ers N, Roth D: A more accurate method to estimate glomerular filtration rate from se-rum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
23. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al: Calibration and random variation of the serum creatinine as-say as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39:920-929. (Pubitemid 34454210)
24. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, et al: Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Insti-tute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 2003; 42: 617-622. (Pubitemid 37187362)
25. Hsu CC, Brancati FL, Astor BC, Kao WH, Steffes MW, Folsom AR, et al: Blood pres-sure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study. J Hypertens 2009; 27: 397-409.
26. Dawson-Hughes B, Harris SS, Dallal GE: Plasma calcidiol, season, and serum para-thyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997; 65:67-71. (Pubitemid 27020461)
27. Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002; 13: 1034-1039. (Pubitemid 34274100)
28. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al: Spontaneous calcifica-tion of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386:78-81. (Pubitemid 27130923)
29. Shea MK, O'Donnell CJ, Hoffmann U, Dallal GE, Dawson-Hughes B, Ordovas JM, et al: Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009; 89:1799-1807.
30. Braam LA, Hoeks AP, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C: Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmeno-pausal women: a follow-up study. Thromb Haemost 2004; 91: 373-380. (Pubitemid 38240185)
31. Shea MK, Booth SL, Massaro JM, Jacques PF, DAgostino RB Sr, Dawson-Hughes B, et al: Vitamin K and vitamin D status: associa-tions with inflammatory markers in the Framingham Offspring Study. Am J Epide-miol 2008; 167: 313-320. (Pubitemid 351197593)
32. Institute of Medicine 2001: Dietary Refer-ence Intakes for Vitamin A, Vitamin K, Ar-senic Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Sili-con, Vanadium, and Zinc. Washington, Na-tional Academy Press, 2001.
33. McKeown NM, Jacques PF, Gundberg CM, Peterson JW, Tucker KL, Kiel DP, et al: Di-etary and nondietary determinants of vita-min K biochemical measures in men and women. J Nutr 2002; 132: 1329-1334. (Pubitemid 34606472)
34. Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF, DAgostino RB Sr, et al: Ge-netic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 2009; 63:458-464.
35. Crosier MD, Peter I, Booth SL, Bennett G, Dawson-Hughes B, Ordovas JM: Association of sequence variations in vitamin K epoxide reductase and 7-glutamyl carboxylase genes with biochemical measures of vitamin K sta-tus. J Nutr Sci Vitaminol (Tokyo) 2009; 55: 112-119.
36. Teichert M, Visser LE, van Schaik RH, Hof-man A, Uitterlinden AG, De Smet PA, et al: Vitamin K epoxide reductase complex sub-unit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study. Arterio-scler Thromb Vasc Biol 2008; 28:771-776. (Pubitemid 351651341)
37. Kohn MH, Price RE, Pelz HJ: A cardiovascu-lar phenotype in warfarin-resistant VKORC1 mutant rats. Artery Res 2008; 2: 138-147.
38. Quteineh L, Verstuyft C, Durrbach A, Le-tierce A, Ferlicot S, Charpentier B, et al: Im-pact of VKORC1 haplotypes on long-term graft function in kidney transplantation. Transplantation 2008; 86:779-783.
39. O'Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS: Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrology, dialy-sis, transplantation: official publication of the European Dialysis and Transplant Asso-ciation - European Renal Association 2011; 26: 2885-2890.
40. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238. (Pubitemid 34787360)
41. Makibayashi K, Tatematsu M, Hirata M, Fu-kushima N, Kusano K, Ohashi S, et al: A vi-tamin D analog ameliorates glomerular in-jury on rat glomerulonephritis. Am J Pathol 2001; 158:1733-1741. (Pubitemid 32422938)
42. 3 preserves glo-merular slit diaphragm-associated protein expression in experimental glomerulone-phritis. Int J Immunopathol Pharmacol 2005; 18: 779-790.
43. Chan JC, Kodroff MB, Landwehr DM: Ef-fects of 1,25-dihydroxyvitamin-D 3 on renal function, mineral balance, and growth in children with severe chronic renal failure. Pediatrics 1981; 68:559-571. (Pubitemid 11026935)
44. Coen G, Mazzaferro S, Manni M, Fondi G, Perruzza I, Pasquali M, et al: No acceleration and possibly slower progression of renal fail-ure during calcitriol treatment in predialysis chronic renal failure. Nephrol Dial Trans-plant 1994; 9: 1520. (Pubitemid 24310304)
45. Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P: 25-Hydroxyvita-min D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009; 20: 2631-2639.
46. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al: Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.
47. Wang L, Manson JE, Song Y, Sesso HD: Sys-tematic review: vitamin D and calcium sup-plementation in prevention of cardiovascu-lar events. Ann Intern Med 2010; 152:315-323.
48. Institute of Medicine 2011: Dietary Refer-ence Intakes for Calcium and Vitamin D. Washington, National Academy Press, 2010.
49. Erkkila AT, Booth SL, Hu FB, Jacques PF, Li-chtenstein AH: Phylloquinone intake and risk of cardiovascular diseases in men. Nutr Metab Cardiovasc Dis 2007; 17: 58-62. (Pubitemid 44881318)
50. Erkkila AT, Booth SL, Hu FB, Jacques PF, Manson JE, Rexrode KM, et al: Phylloqui-none intake as a marker for coronary heart disease risk but not stroke in women. Eur J Clinical Nutr 2005; 59: 196-204. (Pubitemid 40276787)
51. Braam L, McKeown N, Jacques P, Lichten-stein A, Vermeer C, Wilson P, et al: Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. J Am Diet Assoc 2004; 104:1410-1414. (Pubitemid 39166017)